Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 657

1.

Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?

Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, Rageth C.

Eur J Surg Oncol. 2013 Aug;39(8):880-6. doi: 10.1016/j.ejso.2013.05.009. Epub 2013 Jun 2.

PMID:
23735162
2.

Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.

Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, Klimberg VS.

J Am Coll Surg. 2008 May;206(5):1038-42; discussion 1042-4. doi: 10.1016/j.jamcollsurg.2007.12.022. Epub 2008 Mar 3.

PMID:
18471751
3.

Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.

Beek MA, Gobardhan PD, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ.

Eur J Surg Oncol. 2015 Jan;41(1):59-63. doi: 10.1016/j.ejso.2014.09.012. Epub 2014 Oct 29.

PMID:
25468747
4.

The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.

Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, Goto W, Nishiguchi Y, Tokunaga S, Fukushima H, Inoue T.

Eur J Surg Oncol. 2014 Jul;40(7):818-23. doi: 10.1016/j.ejso.2014.03.023. Epub 2014 Apr 15.

PMID:
24768416
5.

Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.

Ponzone R, Cont NT, Maggiorotto F, Cassina E, Mininanni P, Biglia N, Sismondi P.

J Clin Oncol. 2009 Nov 20;27(33):5547-51. doi: 10.1200/JCO.2009.22.1846. Epub 2009 Oct 13.

PMID:
19826123
6.

The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.

Klompenhouwer EG, Gobardhan PD, Beek MA, Voogd AC, Luiten EJ.

Trials. 2013 Apr 25;14:111. doi: 10.1186/1745-6215-14-111.

7.

Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?

Khandelwal R, Poovamma CU, Shilpy C, Prema M, Anthony P.

Breast Dis. 2014 Jan 1;34(4):151-5. doi: 10.3233/BD-140371.

PMID:
24934169
8.

[Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].

Gobardhan PD, Klompenhouwer EG, Beek MA, Voogd AC, Luiten EJ.

Ned Tijdschr Geneeskd. 2013;157(22):A5646. Dutch.

PMID:
23714290
9.

Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.

Helyer LK, Varnic M, Le LW, Leong W, McCready D.

Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.

PMID:
19889169
10.

Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.

Connor C, McGinness M, Mammen J, Ranallo L, Lafaver S, Klemp J, Fan F, Mahnken J.

Ann Surg Oncol. 2013 Oct;20(10):3303-7. doi: 10.1245/s10434-013-3113-4. Epub 2013 Aug 22.

PMID:
23975287
11.

A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.

Yue T, Zhuang D, Zhou P, Zheng L, Fan Z, Zhu J, Hou L, Yu F, Dong X, Xiao L, He Q.

Clin Breast Cancer. 2015 Aug;15(4):301-6. doi: 10.1016/j.clbc.2015.01.010. Epub 2015 Feb 19.

PMID:
25776198
12.

Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.

Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Klimberg VS.

Ann Surg Oncol. 2007 Jun;14(6):1890-5. Epub 2007 May 4.

PMID:
17479341
13.

Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?

Tummel E, Ochoa D, Korourian S, Betzold R, Adkins L, McCarthy M, Hung S, Kalkwarf K, Gallagher K, Lee JY, Klimberg VS.

Ann Surg. 2017 May;265(5):987-992. doi: 10.1097/SLA.0000000000001778.

PMID:
27163955
14.

Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.

Nos C, Clough KB, Bonnier P, Lasry S, Le Bouedec G, Flipo B, Classe JM, Missana MC, Doridot V, Giard S, Charitansky H, Charles-Nelson A, Bats AS, Ngo C.

Eur J Surg Oncol. 2016 Dec;42(12):1827-1833. doi: 10.1016/j.ejso.2016.07.138. Epub 2016 Aug 26.

PMID:
27769634
15.

Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.

Ikeda K, Ogawa Y, Komatsu H, Mori Y, Ishikawa A, Nakajima T, Oohira G, Tokunaga S, Fukushima H, Inoue T.

World J Surg Oncol. 2012 Nov 1;10:233. doi: 10.1186/1477-7819-10-233.

16.

A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.

Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F.

Cancer. 2010 Jun 1;116(11):2543-8. doi: 10.1002/cncr.25096.

17.
18.

Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.

Boneti C, Badgwell B, Robertson Y, Korourian S, Adkins L, Klimberg V.

Minerva Ginecol. 2012 Oct;64(5):421-30.

PMID:
23018481
19.

Axillary reverse mapping: five-year experience.

Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS.

Surgery. 2014 Nov;156(5):1261-8. doi: 10.1016/j.surg.2014.05.011. Epub 2014 Oct 17.

20.

A new technique that complements sentinel lymph node biopsy: lymph node dissection under the intercostobrachial nerves in early-stage breast cancer.

Li J, Jia S, Zhang W, Zhang Y, Qiu F, Xue J, Gu X.

Clin Breast Cancer. 2013 Jun;13(3):212-8. doi: 10.1016/j.clbc.2012.10.005. Epub 2013 Feb 4.

PMID:
23380290

Supplemental Content

Support Center